AMENDMENT # 3 TO RFP ANNOUNCEMENT: IN VITRO AND ANIMAL MODELS FOR EMERGING DISEASES AND BIODEFENSE - NIH-NIAID-RFP-DMID-03-39 RELEASE DATE: January 29, 2003 NOTICE: NOT-AI-03-014 National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov) Receipt Date: February 4, 2003 DESCRIPTION An Amendment has been issued to NIAID solicitation NIH-NIAID-DMID-03-39, entitled, "In vitro and Animal Models for Emerging Diseases and Biodefense." This is Amendment #3, dated January 22, 2003. It provides the following changes to the solicitation: o Revises the Generic Part C Statement of Work to allow the study of botulinum toxin o Revises the instructions for preparation, packaging and delivery of Generic and Task Order proposals o Reduces and defines the content of the Generic and Task Order proposals o Allows Offerors to decide the term of performance for any Task Order Proposals submitted o Informs Offerors that they are not required to submit proposals to the NIAID website o The due date and time for submission of proposals remains Tuesday, February 4, 2003 at 4 PM Local Time. o Offerors are encouraged to review the actual solicitation amendment at http://www.niaid.nih.gov/contract/archive/RFP0339-3.pdf Contracting Office Address: National Institutes of Health National Institutes of Allergy and Infectious Diseases Contract Management Branch 6700-B Rockledge Drive Room 2230, MSC 7612 Bethesda, MD, 20892-7612 Point of Contact: Paul McFarlane, Contracting Officer, Phone 301-496-0349, Fax 301-402-0972, Email pm24@nih.gov
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |